Tags (2) : Kite Pharma
Gilead & Kite Pharma Unveil Breakthrough Cancer Research at ASCO & EHA 2025
05/29/2025 | Companies
American Society of Clinical Oncology,
ASCO,
cancer research,
cancer treatment,
CAR T-cell therapy,
clinical trials,
collaborative research,
EHA,
European Hematology Association,
GileadNews,
hematology,
innovative therapies,
investigational therapy,
Kite Pharma,
metastatic triple-negative breast cancer,
oncology,
Phase 2 results,
recurrent glioblastoma,
refractory multiple myeloma,
relapsed multiple myeloma
Most Popular Now
Environment News
Compliance
Want to write a piece for Daily CSR? Please contact us by email at editor[@]dailycsr.com